References
Jankovic J, Beach J: Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358–362.
Ondo WG, Tintner R, Thomas M, Jankovic J: Tetrabenazine treatment for Huntington’s disease-associated chorea. Clin Neuropharmacol 2002, 25:300–302.
McLellan DL, Chalmers RJ, Johnson RH: A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea. Lancet 1974, 1:104–107.
Jankovic J: Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 1982, 11:41–47.
Allen RP, Picchietti D, Hening WA, et al.: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101–119.
Phillips B, Hening W, Britz P, Mannino D: Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006, 129:76–80.
Earley CJ, Allen RP: Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996, 19:801–810.
Bogan RK, Fry JM, Schmidt MH, et al. ; TREATRLS US Study Group: Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 2006, 81:17–27.
Akpinar S: Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 1982, 39:739.
Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B: Restless legs syndrome improved by pramipexole. A double-blind randomized trial. Neurology 1999, 52:938–943.
Walters AS, Ondo WG, Dreykluft R, et al. ; TREATRLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group: Ropinirole is effective in the treatment of restless legs syndrome TREAT RLS 2: a 12-week, doubleblind, randomized, parallel-group, placebo-controlled study. Mov Disord 2004, 19:1414–1423.
Ondo W, Romanyshyn J, Vuong KD, Lai D: Long-term treatment of restless legs syndrome with dopamine agonists. Arch Neurol 2004, 61:1393–1397.
Moller JC, Korner Y, Cassel W, et al.: Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome. Sleep Med 2006, In press.
Dodd ML, Klos KJ, Bower JH, et al.: Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005, 62:1377–1381.
Rights and permissions
About this article
Cite this article
Morgan, J.C., Sethi, K.D. Ropinirole versus placebo in primary restless legs syndrome. Curr Neurol Neurosci Rep 6, 278–280 (2006). https://doi.org/10.1007/s11910-006-0018-7
Issue Date:
DOI: https://doi.org/10.1007/s11910-006-0018-7